Shihong Wei

机构：Chongqing University of Posts and Telecommunications, Gansu Provincial Hospital · ORCID：0009-0008-1211-2751

发表论文 52 篇 · 总被引 537 次 · h-index 11

代表论文

• Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial (2024 · Nature Medicine · 被引 130)
• Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 82)
• Thoracic Radiotherapy Improves the Survival in Patients With EGFR -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial (2024 · Journal of Clinical Oncology · 被引 52)
• A model for early rumor detection base on topic-derived domain compensation and multi-user association (2024 · Expert Systems with Applications · 被引 23)
• A recommendation model for e-commerce platforms oriented to explicit information compensation and hidden information mining (2024 · Knowledge-Based Systems · 被引 12)
• Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial (2025 · The Lancet Oncology · 被引 11)